Skip to main content
. 2023 Oct 29;9(11):e21761. doi: 10.1016/j.heliyon.2023.e21761

Table 3.

Comparison of prognostic biomarkers between T0 vs. T1, T2, T3 and T4 and percentage of change (% change) between T1, T2, T3 and T4 vs T0.

Mean ± SD (T0) Mean ± SD (T1) Mean ± SD (T2) Mean ± SD (T3) Mean ± SD (T4) % of change
T1 vs T0
% of change
T2 vs T0
% of change
T3 vs T0
% of change
T4 vs T0
Glycemia (mg/dL) 100.52 ± 11.93 91.97 ± 11.19*** 90.45 ± 10.88*** 95.41 ± 11.25** 97.6 ± 12.16 −8.51 % −10.02 % −5.08 % −2.82 %
Insulin (microU/mL) 7.83 ± 4.80 6.74 ± 4.40* 6.16 ± 3.64** 6.59 ± 3.60* 6.84 ± 3.75 −13.95 % −21.29 % −15.84 % −12.59 %
HOMA-IR index 2.04 ± 1.58 1.60 ± 1.26** 1.44 ± 1.47** 1.61 ± 1.08* 1.69 ± 1.06 −21.88 % −29.60 % −21.20 % −17.26 %
Triglycerides (mg/dL) 103.17 ± 44.37 94.24 ± 41.35 89.86 ± 36.21* 86.76 ± 42.69* 94.83 ± 41.96 −8.66 % −12.90 % −15.91 % −8.08 %
HDL (mg/dL) 62.62 ± 16.09 61.00 ± 13.71 60.62 ± 13.56 65.41 ± 12.82 64.38 ± 15.59 −2.59 % −3.19 % 4.46 % 2.81 %
LDL (mg/dL) 136.00 ± 28.93 125.07 ± 28.22** 129.14 ± 27.33 129.55 ± 24.20 127.76 ± 23.65* −8.04 % −5.04 % −4.74 % −6.06 %
Total cholesterol (mg/dL) 216.45 ± 39.28 207.38 ± 37.43* 208.41 ± 37.20 206.59 ± 32.01* 214.83 ± 33.52 −4.19 % −3.71 % −4.56 % −0.75 %
Progesterone (ng/mL) 0.49 ± 0.40 0.45 ± 0.19 1.16 ± 3.53 1.01 ± 3.31 0.71 ± 1.36 −6.12 % 138.78 % 106.12 % 44.90 %
Testosterone (ng/mL) 0.31 ± 0.26 0.20 ± 0.17** 0.24 ± 0.16** 0.27 ± 0.17 0.27 ± 0.17 −35.39 % −23.55 % −12.72 % −14.77 %
hs-Troponin (ng/L) 2.97 ± 1.21 2.86 ± 2.80 2.93 ± 1.16 3.14 ± 1.95 2.66 ± 1.51 −3.70 % −1.35 % 5.72 % −10.44 %

Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs, high sensitive; T0, baseline; after 3 (T1); 6 (T2); 12 (T3), and 24 (T4) months after the lifestyle intervention; bold values denote statistical significance with a p < 0.05 (*); p < 0.01 (**); or p < 0.001 (***).